Wang Huashe, Chen Yonghe, Liu Aihong, Xiang Jun, Lin Yijia, Wen Yue'e, Wu Xiaobin, Peng Junsheng
Department of Gastrointestinal Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Dec 25;20(12):1393-1398.
To describe and analyze the complications of subcutaneous venous access port for patients with gastrointestinal malignancy.
Data of 1 912 patients with gastrointestinal malignancy who accepted chemotherapy in our department via subcutaneous venous access ports, including 127 cases in upper arm, 865 cases in subclavicular vein and 920 cases in internal jugular vein, from June 2007 to April 2016 were analyzed retrospectively. Associated complications and risk factors were emphatically investigated.
Postoperative complications were confirmed in 233 patients(12.2%), and complication morbidity was 37.0%(47/127), 15.5%(134/865), 6.7%(62/920) in upper arm group, subclavicular vein group, internal jugular vein group respectively, whose difference was statistically significant (χ=71.060, P=0.000). Sixty-one(3.2%) patients developed early complications (in the day of insertion, including catheter dislocation, pneumothorax, arterial damage). Early complication morbidity of upper arm group (14.2%, 18/127) was higher as compared to subclavicular vein group (3.4%, 29/865) and internal jugular vein group(1.5%, 14/920) with significant difference (χ=57.867, P=0.000). Postoperative long-term complications (catheter dislocation, thrombosis, pinch-off syndrome, infusion base exposure, catheter detachment) were found in 182(9.5%) patients. Morbidity of long-term complication was 5.2%(48/920) in internal jugular vein group, which was significantly lower than 22.8% (29/127) in upper arm group and 12.1% (105/865) in subclavicular vein group with statistically significant difference (χ=50.828, P=0.000). Multivariate analysis indicated that subclavicular vein intubation (OR=0.536, 95%CI: 0.341 to 0.843; P=0.007 OR=0.156, 95%CI: 0.096 to 0.253, P=0.000), internal jugular vein intubation (OR=0.156, 95%CI: 0.096 to 0.253, P=0.000), operation time <40 minutes (OR=0.458, 95%CI: 0.342 to 0.613, P=0.000) and standardized training (OR=0.233,95%CI: 0.171 to 0.318, P=0.000) were protective factors of postoperative complication; besides, subclavicular vein intubation (OR=0.458, 95%CI: 0.342 to 0.613, P=0.000), internal jugular vein intubation (OR=0.233, 95%CI: 0.171 to 0.318, P=0.000) and standardized training (OR=0.313, 95%CI: 0.173 to 0.568, P=0.000) were protective factors of thrombosis.
Subcutaneous venous access port implantation is a preferable access to central vein. Appropriate intubation approach and standardized training may reduce postoperative complications effectively. Internal jugular vein approach is safer and more reliable than upper arm vein and subclavian vein approach.
描述并分析胃肠道恶性肿瘤患者皮下静脉输液港的并发症。
回顾性分析2007年6月至2016年4月在我科经皮下静脉输液港接受化疗的1912例胃肠道恶性肿瘤患者的数据,其中上臂置管127例,锁骨下静脉置管865例,颈内静脉置管920例。重点调查相关并发症及危险因素。
233例患者(12.2%)出现术后并发症,上臂组、锁骨下静脉组、颈内静脉组并发症发生率分别为37.0%(47/127)、15.5%(134/865)、6.7%(62/920),差异有统计学意义(χ=71.060,P=0.000)。61例(3.2%)患者发生早期并发症(置管当日,包括导管移位、气胸、动脉损伤)。上臂组早期并发症发生率(14.2%,18/127)高于锁骨下静脉组(3.4%,29/865)和颈内静脉组(1.5%,14/920),差异有统计学意义(χ=57.867,P=0.000)。182例(9.5%)患者出现术后长期并发症(导管移位、血栓形成、夹闭综合征、输液座外露、导管脱出)。颈内静脉组长期并发症发生率为5.2%(48/920),显著低于上臂组的22.8%(29/127)和锁骨下静脉组的12.1%(105/865),差异有统计学意义(χ=50.828,P=0.000)。多因素分析表明,锁骨下静脉置管(OR=0.536,95%CI:0.341至0.843;P=0.007 OR=0.156,95%CI:0.096至0.253,P=0.000)、颈内静脉置管(OR=0.156,95%CI:0.096至0.253,P=0.000)、手术时间<40分钟(OR=0.458,95%CI:0.342至0.613,P=0.000)和标准化培训(OR=0.233,95%CI:0.171至0.318,P=0.000)是术后并发症的保护因素;此外,锁骨下静脉置管(OR=0.458,95%CI:0.342至0.613,P=0.000)、颈内静脉置管(OR=0.233,95%CI:0.171至0.318,P=0.000)和标准化培训(OR=0.313,95%CI:0.173至0.568,P=0.000)是血栓形成的保护因素。
皮下静脉输液港植入是一种较好的中心静脉通路。合适的置管方法和标准化培训可有效减少术后并发症。颈内静脉途径比上臂静脉和锁骨下静脉途径更安全可靠。